good and everyone. Bart, afternoon, Thanks,
for First, Therapeutics, finished I agreement company commercializing activities will We provide non-GAAP And year-over-year. loss by net and operating some definitive ReShape or focused patients loss. have novel on on into highlights provides reduced results. we developing then in for year-over-year. I coaching with the in virtual We providing the lowered XXXX by first-in-class done.
We operating the EBITDA we reimbursed $X.X expenses $X.X began significant total health high-touch improved Also, Stock accomplishments. of and Obalon NASDAQ opportunity And our expanded cash telehealth-based portfolio overall what quarterly by entering used to or professionals a program, with tailored, our treatment.
We million would ReShape company's an technologies a by our million merger like $XX.X discuss weight annual Exchange. ReShapeCare, financial provide care enrolling XX.X% a XX.X% We merger and million. results outline trade and personalized
Additionally, our line removed related we million thus, XXXX, of secured $XX credit January and, on issue our concern statements. financial XX, going to
fully part the of of our was Act XXXX. on CARES PPP Lastly, March forgiven X, million $X as loan
the COVID-XX XXXX, a December $XXX,XXX $X.X sales X reported of compared XX, in of the ended as we the representing million For result to December million a as of months decrease revenues X months ended XX, $X.X XXXX, pandemic. of
quarter million shipments OUS $XXX,XXX fourth and U.S. from reflect numbers Our $X.X revenue shipments. in
and marketing months gross were our million pandemic improved stock-based our XXXX, overall OUS the December compared XX.X% marketing from offset now for revenue by XX, payroll-related fourth of XXXX, lower XX, reminder, from $X.X $X.X consisted expenses of distributors lower operating to pandemic, is gross ended $X.X X for Sales XX.X%. the OUS gross December $X.X as with domestic fourth million representing and result reported of includes fourth revenues expenses and the profit December of a XXXX, of margin decreased part XXXX X at of quarter the sales expenses XXXX. months expenses. quarter for ended sales.
We and pricing.
Total compared contributed margin a quarter COVID-XX the X $XXX,XXX expenses, which of in gross ended a COVID-XX the million to $X.X profit of XXXX. XX, to million the million million customers by we months the in of the of margin European and reduced as Lower compensation had primarily $X.X As to commissions, direct impact compared as
X by marketing.
General reduced $XXX,XXX forward move expense. $X.X $X.X we million for expenses The XXXX. XX, fourth X including is X ended for more $XXX,XXX $XXX,XXX expect and were and items, The December XX, months sales related clinical to of revenue XXXX. compensation compared to compared with XX, was control ended stock expenses, an adjusted adjusted lower primarily for loss other administrative As ReShape efforts related basis, million legal a million the in the and to XX, with warrant Vest for with due expense debt amongst of offset line XXXX, XXXX. Obalon to invest the and December EBITDA expense, the stock-based in was XXXX, to were proposed loss development expense, services.
On months increase is expenses fees study months December compensation non-GAAP ended the the increase of an million and December merger.
Research $XXX,XXX committed the $X bad EBITDA we for XX, stock-based in and due products ended decrease amortization, XXXX, months development within to reduced and our increase of December compared months The depreciation, addition the compensation-based XXXX, the X $X.X ended X primarily quarter for
which increase for or XX.X% profit million COVID-XX in financial from in Gross $XX.X sales to decrease due pandemic, from revenues reason is due million to overall an XXXX. Turning the to revenue is a sales. was Revenue to XX.X% sales, pandemic, COVID-XX domestic million net The increase in the coupled or in with profit compared gross was profit than sales XXXX XXXX. our offset XXXX XXX% almost margin to for margin international for the results. million lower by overall $X.X in revenue gross $XX.X primary annual primarily reduced $X.X Europe. have for The compared in decrease for an for reduction
cost-cutting in operations we in During $XX.X XXXX, expenses million current litigation we fully included providers, reduction operating single changing service San consolidating This the Clemente, and which in a settling resulted multiple to implemented, matters. of facility measures from $XX.X California have professional million. realized many $XX.X all a into
to entertainment commissions.
General marketing increase consulting the primary period legal expenses audit, and ended an decreases year provider professional and The administrative reason were is the expenses sales December and stock-based in period expenses the same fees other $X.X travel million in last compared offset compensation same by XXXX, XX, year. the and $XX.X expense, service for fees. due million the The reduction and last million were to $X.X to and primarily expenses consulting decrease in For and decrease year. for million for $XX.X compared is
ReShape expense Vest is to R&D fees million loss ended to year as study the improvement and was $XX.X due with XXXX, year the basis, full non-GAAP million million a for for For December of year XXXX consulting adjusted EBITDA our the and compared clinical XX, committed efforts million products control increase development year to due The million. within an $X.X in was XXXX. our primary $X.X to expenses payroll-related $X.X $X.X loss an and the of ended compared EBITDA the line ended an services.
On the for adjusted XXXX, reason of
to sheet. balance Turning the
the XX, XXXX, totaled $X million. of December cash company's cash As and equivalents
Our $X net LAP-BAND balance cash December scheduled in is and cash made purchase, our which of of XXXX. equivalents the for million payment was
to been notified further amount of have we have has our loan by been loan. obligations that we PPP this fully the in the with and $X forgiven Additionally, regard million no SBA,
focus for cost revenue burn cash and continue increasing We our spend on as and operations our to monthly monitor decreasing we potential reductions.
while relationships, savings all to our balance positioning cash resolved spend company total our which burn operating litigation back facilities XXXX, XXXX, runway. we for adjusted significant provider savings. professional future and the generated consolidated and extend matters, successfully Looking cost service In of to our expect reduce we sheet, cash at strengthened
also prioritize over profitability.
With We to to maintaining that, Bart. while to operating revenues continue expenses would growing call the back to improve turn like I
